Separately, Raymond James lowered Teligent from a strong-buy rating to an outperform rating in a research note on Tuesday, March 19th.
Shares of TLGT stock opened at $0.68 on Thursday. The company has a quick ratio of 0.79, a current ratio of 1.46 and a debt-to-equity ratio of 14.43. Teligent has a 52-week low of $0.66 and a 52-week high of $4.52. The stock has a market capitalization of $46.73 million, a PE ratio of -2.06 and a beta of 1.45.
Several institutional investors have recently made changes to their positions in TLGT. Millennium Management LLC purchased a new position in shares of Teligent in the 4th quarter valued at about $39,000. Paloma Partners Management Co purchased a new position in shares of Teligent in the 4th quarter valued at about $40,000. Raymond James & Associates increased its stake in shares of Teligent by 21.9% in the 4th quarter. Raymond James & Associates now owns 36,700 shares of the company’s stock valued at $50,000 after purchasing an additional 6,600 shares in the last quarter. Raymond James Financial Services Advisors Inc. purchased a new position in shares of Teligent in the 1st quarter valued at about $55,000. Finally, SG Americas Securities LLC purchased a new position in shares of Teligent in the 4th quarter valued at about $60,000. Hedge funds and other institutional investors own 64.59% of the company’s stock.
Teligent Company Profile
Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. It offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.
Featured Story: What is Forex?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.